Publicaciones en colaboración con investigadores/as de Cardiff University (23)

2022

  1. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis

    The Lancet Haematology, Vol. 7, Núm. 10, pp. e746-e755

  2. Oral immunogenicity in mice and sows of enterotoxigenic escherichia coli outer‐membrane vesicles incorporated into zein‐based nanoparticles

    Vaccines, Vol. 8, Núm. 1

  3. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis

    Journal of Thrombosis and Haemostasis, Vol. 18, Núm. 8, pp. 1940-1951

2019

  1. Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy

    Journal of Pharmaceutical Sciences, Vol. 108, Núm. 7, pp. 2421-2429

  2. Modulation of the fate of zein nanoparticles by their coating with a Gantrez® AN-thiamine polymer conjugate

    International Journal of Pharmaceutics: X, Vol. 1

2017

  1. First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    The Lancet Oncology, Vol. 18, Núm. 9, pp. 1159-1171

  2. Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: The N3 i PD study (nigrosomal i ron i maging i n Parkinson's disease)

    BMJ Open, Vol. 7, Núm. 12

  3. Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.

    International Journal of Pharmaceutics, Vol. 533, Núm. 1, pp. 236-244

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

  2. Shared genetic contribution to ischemic stroke and Alzheimer's disease

    Annals of Neurology, Vol. 79, Núm. 5, pp. 739-747

2015

  1. Convergent genetic and expression data implicate immunity in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 11, Núm. 6, pp. 658-671

2014

  1. Classification of current anticancer immunotherapies

    Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508

  2. Frontotemporal dementia and its subtypes: A genome-wide association study

    The Lancet Neurology, Vol. 13, Núm. 7, pp. 686-699

  3. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

    PLoS ONE, Vol. 9, Núm. 6

2013

  1. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

    Journal of Thrombosis and Haemostasis, Vol. 11, Núm. 1, pp. 71-80

  2. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

    Journal of Thrombosis and Haemostasis, Vol. 11, Núm. 1, pp. 56-70

  3. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Nature Genetics, Vol. 45, Núm. 12, pp. 1452-1458

  4. Suicidal ideation in a European Huntington's disease population

    Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258